DraftUnitedHealthcarePolicy CS097NE.S

Pneumatic Compression Devices (for Nebraska Only)

State-specific UnitedHealthcare policy governing coverage and clinical criteria for pneumatic compression devices (PCDs) for members in Nebraska; includes guidance on lymphedema, DVT prevention, and peripheral arterial disease treatments.

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices (for Nebraska Only)

Policy CodePolicy CS097NE.S

Change TypeCode list update (HCPCS added)

Effective DateDec 1, 2025

Next Review DateN/A

Key ActionFollow InterQual CP criteria and submit supporting clinical documentation when requesting authorization, using the policy's current HCPCS codes.

SourceLink

POLICY UPDATE CHANGES

Updated list of applicable HCPCS codes to reflect quarterly edits; added E0658 and E0659.

Nebraskastate applicability

Multiple HCPCSapplicable billing codes

UnprovenAPCD head/neck stance

Proven (select)DVT prevention stance

RCTs & meta-analysesevidence sources

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

inv-01: InterQual-based Covered Indications

Covered when clinical criteria per InterQual are met for indications where pneumatic/compression devices are proven medically necessary.

InterQual-based medical necessity: Coverage requires meeting InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices clinical criteria for the specific indication (for example, lymphedema or DVT prevention).

Providers must reference InterQual for the detailed clinical entry criteria and supply supporting documentation as specified by InterQual.

inv-02: Explicit Not Medically Necessary Uses

Not covered / not medically necessary in specific situations:

Unproven/Not Medically Necessary Uses: Advanced intermittent pneumatic compression devices (APCDs) for lymphedema of the head, face, or neck and high‑pressure, rapid inflation/deflation cycle pneumatic compression devices for peripheral arterial disease (PAD) are considered unproven and not medically necessary.

See evidence summaries for head/neck lymphedema and PAD for rationale and citations.

inv-03: Indication-specific coverage rationale

Coverage considerations reflected by cited guidelines and trials:

Chronic limb‑threatening ischemia (CLTI): Arterial IPC may be considered for patients with CLTI when revascularization is not possible to augment wound healing or relieve rest pain (guideline grade ~2B); document specialist assessment and rationale.

ESVS and AHA/ACC guideline statements referenced.

Venous leg ulcer (VLU): IPC may be considered as an adjunct to standard compression therapy for large or painful venous ulcers or when other compression options are unavailable, cannot be used, or have failed; standard multilayer/IB/ACG with target ~≥40 mmHg at the ankle remains first‑line for active VLU.40 mmHg ankle target (multilayer/IB/ACG)

Supported by ESVS guidance and a small RCT (Alvarez et al.) showing faster healing with adjunctive IPC.

Lymphedema/Chronic venous disease (CVD): IPC or dual‑action PCDs can be comparable to compression stockings for patient‑centered outcomes in CVD/lymphedema; consider individual patient factors (eg, BMI) when selecting therapy.

inv-04: Covered Indications (summary)

Covered when supported by clinical indications and guideline‑based rationale (examples):

IPC for DVT prophylaxis in immobile or post‑operative patients: Intermittent pneumatic compression reduces DVT incidence in immobile patients (eg, CLOTS 3 showed a significant reduction in DVT and improved survival) and in early post‑operative immobilized outpatients (eg, Achilles tendon repair trials showing reduced DVT at 2 weeks).

Use when patient meets trial‑defined immobility or procedure‑related immobilization criteria; document duration and contraindications.

IPC when pharmacologic prophylaxis contraindicated: Guidelines recommend mechanical prophylaxis (IPC) over no prophylaxis for patients at high bleeding risk or when pharmacologic agents are contraindicated.

ASH and European guidelines provide conditional recommendations to prefer mechanical methods in high bleeding risk.

Advanced pneumatic compression for head/neck lymphedema per device labeling: Advanced pneumatic compression systems cleared for head/neck lymphedema (eg, Flexitouch Plus) may be considered when used consistent with FDA clearance and supporting clinical evidence; coverage requires documentation per InterQual and device labeling.

The policy designates certain advanced pneumatic compression systems as not medically necessary when used outside supported indications. Specifically, advanced pneumatic compression devices (APCDs) for lymphedema of the head, face, or neck are considered unproven and not medically necessary, and high‑pressure, rapid inflation/deflation cycle pneumatic compression devices for peripheral arterial disease (PAD) are similarly considered unproven and not medically necessary. For all other indications the policy requires meeting InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices clinical criteria to establish medical necessity.

Clinical trial protocols and major guideline documents have excluded or cautioned against IPC use in patients with certain limb or systemic conditions. Trial exclusion criteria commonly listed include dermatitis, leg ulcers, severe edema, severe peripheral vascular disease, and congestive cardiac failure. NICE guidance also recommends against mechanical prophylaxis in patients with suspected or proven peripheral arterial disease, peripheral arterial bypass grafting, peripheral neuropathy or sensory impairment, fragile skin/dermatitis/gangrene or recent skin graft, severe leg edema, or major limb deformity preventing correct fit.

Consistent with NICE guidance, the policy states that mechanical prophylaxis (including PCDs/IPC) should not be used in patients with suspected or proven peripheral arterial disease. Devices that cannot be properly fitted or that may harm fragile skin or compromise arterial flow are contraindicated; document any limb vascular or local skin conditions when considering IPC.

Advanced anatomic applications and certain device designs lack sufficient evidence of benefit. The policy explicitly considers APCDs for head/face/neck lymphedema and some rapid‑cycle, high‑pressure pneumatic compression devices (notably those promoted for arterial insufficiency) to be unproven and not medically necessary; additional prospective controlled evidence is required to establish clinical value for these uses.

Randomized trial evidence in critically ill ICU populations shows no reduction in proximal lower‑limb DVT when intermittent pneumatic compression (IPC) is added to pharmacologic thromboprophylaxis. A large multicenter RCT of 2,003 critically ill patients found no significant difference in proximal DVT (3.9% vs 4.2%) or 90‑day mortality with adjunctive IPC versus pharmacologic prophylaxis alone, and authors concluded no benefit for routine adjunctive IPC in this population.

Guideline syntheses note that mechanical prophylaxis alone is not supported by most evidence for many patients. The 2024 European perioperative VTE guideline highlights that mechanical methods alone generally lack sufficient evidence and that combined mechanical plus pharmacologic prophylaxis may be appropriate only in select very high‑risk patients; thus mechanical prophylaxis as the sole modality is generally not recommended except when pharmacologic prophylaxis is contraindicated.

Coding

Applicable HCPCS CodesHCPCS

A4600	Sleeve for intermittent limb compression device, replacement only, each.
E0650	Pneumatic compressor, nonsegmental home model.
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure.
E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure.
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg.

1–10 of 19

1/2

Applicable HCPCS Codes (updated)HCPCS

E0658	newly added HCPCS code as listed in policy
E0659	newly added HCPCS code as listed in policy

FDA Product Codesmixed

JOW	FDA product code for pneumatic compression devices

Provider Actions & Authorization

Prior Authorization

Prior Authorization Required

Prior authorization is required for intermittent pneumatic compression (IPC) devices when used to treat limb ischemia (peripheral arterial disease/critical limb ischemia) or venous leg ulceration (VLU). Requests must reference InterQual® CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices criteria to establish medical necessity.

Prior auth required for IPC in limb ischemia and VLU; include clinical rationale and InterQual criteria reference.
Ensure benefit plan terms (federal/state/contractual) are checked — plan language governs coverage decisions.

Billing Rule

Use Updated HCPCS Codes for Authorization

Use the updated HCPCS code set effective 12/01/2025 when submitting authorization requests and claims. The HCPCS list in this policy is illustrative; verify quarterly edits before billing.

Rental, Purchase & Replacement Rules

HCPCS Code	Description	Coverage Status
A4600
Sleeve for intermittent limb compression device, replacement only, each.
Neutral
E0650
Pneumatic compressor, nonsegmental home model.
Neutral
E0651
Pneumatic compressor, segmental home model without calibrated gradient pressure.
Neutral
E0652
Pneumatic compressor, segmental home model with calibrated gradient pressure.
Neutral
E0655
Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
Neutral
E0658
Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
Neutral
E0659
Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
Neutral
E0660
Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
Neutral
E0665
Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.
Neutral
E0666
Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg.
Neutral
E0667
Segmental pneumatic appliance for use with pneumatic compressor, full leg.
Neutral
E0668
Segmental pneumatic appliance for use with pneumatic compressor, full arm.
Neutral
E0669
Segmental pneumatic appliance for use with pneumatic compressor, half leg.
Neutral
E0670
Segmental pneumatic appliance for use with pneumatic compressor, integrated, two full legs and trunk.
Neutral
E0671
Segmental gradient pressure pneumatic appliance, full leg.
Neutral
E0672
Segmental gradient pressure pneumatic appliance, full arm.
Neutral
E0673
Segmental gradient pressure pneumatic appliance, half leg.
Neutral
E0675
Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system).
E0676
Intermittent limb compression device (includes all accessories), not otherwise specified
Neutral

Device Type	Clinical Notes / Evidence	Coverage Status
Dual-action therapy PCDs
Randomized and pilot studies (eg, Lurie et al. 2017) show dual-action PCDs comparable to compression stockings for chronic venous disease; may offer volume reduction in obese patients.
Neutral
Intermittent pneumatic compression (IPC) devices
IPC is supported to reduce DVT incidence in immobile post-stroke patients (CLOTS3) and may be an adjunct for venous leg ulcers when standard compression has failed (Alvarez et al. 2020).
Neutral
Advanced pneumatic compression systems (APCDs)
Advanced systems cleared for head/neck lymphedema exist (eg, Flexitouch) but head/neck APCDs are considered unproven for some indications in policy; FDA clearance alone is informational.
Neutral

Topic	Directive / Guidance	Reference
State-specific rental/purchase rules
Refer to Nebraska Medicaid DME rules for pneumatic compressors and appliances for state-specific rental versus purchase guidance.
Nebraska Medicaid, Chapter 7 (Code 471) - Pneumatic Compressors and Appliances

Garments/sleeves (A4600) and appliances

Garment HCPCSA4600 — Sleeve for intermittent limb compression device, replacement only, each.

Appliance examplesE0660, E0666, E0667, E0669 — nonsegmental/segmental pneumatic appliances for full/half leg and related garments.

Arm & trunk appliancesE0655, E0665, E0668 — half arm, full arm, and segmental full-arm appliances for use with compressors.

IPC devices

Home-model compressorsE0650 — Pneumatic compressor, nonsegmental home model.

Segmental compressor codes

Medical Necessity

inv-33: InterQual-based necessity

Medical necessity determinations are delegated to InterQual; providers must follow InterQual clinical criteria and document support per those criteria.

InterQual adherence: Device rental or purchase coverage requires meeting the InterQual CP clinical criteria for the specific indication and device type.

InterQual contains the detailed clinical nodes (not reproduced here); providers should reference InterQual and supply supporting clinical documentation as required.

inv-34: DME medical necessity criteria

Medical necessity scenarios supported by evidence (operational criteria to document):

Post‑stroke immobility: Device is medically necessary when patient is immobile after acute stroke (unable to get out of bed/chair and walk to the toilet without help) and there are no contraindications to IPC; intended to reduce DVT risk and improve survival as shown in CLOTS 3.Immobility per trial definition

Documentation Requirements

Documentation Required

Document medical necessity per InterQual and tie to device

Follow the InterQual CP criteria and include supporting clinical documentation that ties the specific indication to the requested device per InterQual's nodes and thresholds.

Documentation Required

Provide clinical notes for immobility, prior compression use/failure, and contraindications

Include clinical notes that demonstrate immobility (e.g., unable to get out of bed/chair and walk to toilet without help), prior use and failure of standard compression therapy, and documentation that contraindications to IPC are absent.

Record duration and degree of immobility when applicable
Document prior compression modalities tried and clinical response
Document absence of exclusionary conditions (severe PVD, dermatitis, severe edema, CHF)

Not Covered / Exclusions

Not covered: APCDs for lymphedema of the head, face, or neck and high‑pressure, rapid inflation/deflation pneumatic compression devices intended for peripheral arterial disease are considered unproven and are listed as not covered / not medically necessary under this policy.

Not covered: routine use of adjunctive IPC in critically ill ICU patients who are already receiving pharmacologic thromboprophylaxis is considered not medically necessary based on randomized evidence showing no reduction in DVT incidence with routine adjunctive IPC.

Not covered: mechanical prophylaxis (including PCDs/IPC) used as the sole method of VTE prevention when pharmacologic prophylaxis is indicated and not contraindicated, or used in limbs with contraindicated local conditions (eg, PAD, fragile skin, recent grafts, severe edema), may be considered not supported and therefore not covered. Documented contraindications to pharmacologic prophylaxis are required to justify mechanical‑only use.

Definitions and Background

Background: Pneumatic compression devices (PCDs) are powered systems that attach to inflatable garments and sequentially apply pressure to increase venous and lymphatic flow. Devices range from basic intermittent pneumatic compression (IPC) sleeves for the limbs to more complex, programmable advanced pneumatic compression devices (APCDs) with specialized garments for anatomical regions such as the head and neck. Indications include lymphedema management and VTE prophylaxis, but clinical evidence and guideline recommendations vary by device type and patient population.

Intermittent pneumatic compression (IPC)

DefinitionIntermittent pneumatic compression (IPC): inflatable sleeves wrapped around the legs (calf or calf+thigh) that inflate sequentially or distally-to-proximally to increase venous flow and reduce thrombosis risk.

Typical use caseUsed for DVT prophylaxis in immobile or postoperative patients and to augment venous return by sequential inflation.

Device componentsCompressor unit plus single- or multi-chambered garments; may be segmental or nonsegmental models.

Advanced pneumatic compression devices (APCDs)

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices (for Nebraska Only)

Policy CodePolicy CS097NE.S

Change TypeCode list update (HCPCS added)

Effective DateDec 1, 2025

Next Review DateN/A

Key ActionFollow InterQual CP criteria and submit supporting clinical documentation when requesting authorization, using the policy's current HCPCS codes.

SourceLink

On This Page

Small RCTs and pilot studies cited (Lurie et al.).

DVT prophylaxis after stroke: IPC is supported to reduce DVT incidence and improve survival in immobile patients after acute stroke (eg, CLOTS 3 and systematic reviews); apply in patients meeting immobility definitions used in trials.Immobility per trial definition (unable to get up from a chair/out of bed and walk to toilet without help)

Supported by CLOTS3 and related HTA analyses.

Surgical/orthopedic and ICU settings: Evidence is mixed: IPC reduces early DVT risk in some postoperative immobilized outpatients and is recommended by various guidelines; however, adjunctive IPC added to pharmacologic prophylaxis in some critically ill ICU populations did not show additional benefit—use guideline‑based risk assessment.

Trials include postoperative Achilles tendon repair and large ICU RCTs with heterogeneous results.

FDA clearance and pilot/feasibility studies cited; policy treats some APCD uses as unproven for head/neck unless criteria met.

Updated codes include additions E0658 and E0659 (added 12/01/2025).
Confirm current HCPCS file for any subsequent quarterly edits.

Denial Risk

Devices for Arterial Insufficiency (HP Rapid-Cycle)

High-pressure, rapid inflation/deflation cycle pneumatic compression devices intended for arterial insufficiency (HCPCS E0675) are considered unproven and not medically necessary — these devices are not appropriate for PAD/arterial insufficiency. Use of such devices may be denied.

Devices for arterial insufficiency (high-pressure, rapid-cycle) are not medically necessary (E0675).
Do not substitute high-pressure rapid-cycle devices for standard IPC when PAD is the primary diagnosis.

Denial Risk

Potential Denials, Trial Exclusions, and Coding Mismatch Risk

Authorization requests lacking required clinical documentation or showing conflicting coding may be denied. Include clear documentation of prior conservative/compression-first management where applicable, and document why compression alternatives were unavailable or failed for VLU.

Required clinical documentation (see separate documentation callout).
Potential denial triggers: use of E0675 for arterial disease, absence of InterQual criteria alignment, missing evidence of failed/contraindicated standard compression for VLU.
Coding mismatch risk: ensure HCPCS reported on auth request matches device delivered and the code set effective on date of service.

Documentation Required

Required Clinical Documentation

Provide the following clinical documentation with authorization requests: diagnosis and supporting clinical findings; prior conservative/compression therapy trial and outcomes; vascular assessment results (e.g., ankle-brachial index, toe pressures, or TcPO2 when arterial disease suspected); wound characteristics and prior ulcer treatments for VLU; documentation that revascularization is not feasible when IPC is considered for limb ischemia.

Vascular testing (ABI, toe pressure, TcPO2) if arterial component suspected.
Documentation of compression-first management or reason it was contraindicated/unavailable for VLU.
InterQual CP citation and any relevant imaging or vascular surgery consult notes.

Step Therapy

InterQual-Guided Steps and Compression-First Expectation

InterQual-guided step considerations: follow InterQual criteria to determine when IPC is appropriate vs when alternative compression (elastic stockings, multilayer bandaging, adjustable compression garments) is required first. For VLU, compression-first is expected when clinically appropriate; IPC is considered when other compression options are not available, cannot be used, or have failed.

InterQual criteria required to establish medical necessity per policy.
Compression-first expectation for active VLU: multilayer, inelastic bandages, or adjustable compression garments targeting recommended pressures (e.g., ≥40 mmHg at the ankle) should be tried prior to IPC when feasible.

E0651, E0652 — Segmental home models (without/with calibrated gradient pressure).

Intermittent limb device codeE0676 — Intermittent limb compression device (includes all accessories), not otherwise specified.

Pneumatic compression devices and garments

APCD garment codes (head/neck) E0659 — Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.

Integrated multi-limb appliance codesE0670 — Segmental pneumatic appliance integrated, two full legs and trunk; E0658 — integrated 2 full arms and chest.

High-pressure rapid-cycle cautionE0675 — Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (listed as unproven/not medically necessary).

Document duration of immobility, contraindications (eg, dermatitis, leg ulcers, severe peripheral vascular disease), and any pharmacologic prophylaxis use.

Non‑healing venous leg ulcer adjunct: Device is medically necessary as an adjunct when large or painful venous leg ulcers have failed adequate standard compression therapy or when standard compression cannot be applied; document prior compression attempts or contraindications.Ulcer >1 year or >20 cm^2 as in cited RCT

Small RCT evidence (Alvarez et al.) supports faster healing when IPC is added to standard compression in selected hard‑to‑heal ulcers.

CLTI without revascularization option: Arterial IPC may be considered for patients with chronic limb‑threatening ischemia when revascularization is not possible to augment wound healing or relieve rest pain; document vascular specialist assessment and rationale.

ESVS/AHA‑ACC guideline statements grade recommendation approximately 2B.

inv-35: DME Medical Necessity Criteria — listed clinical scenarios

Medical necessity generally requires documentation of one or more of the following clinical scenarios:

Immobile hospitalized patients at risk for DVT: Use IPC in immobile hospitalized patients at elevated VTE risk (eg, post‑stroke patients meeting trial immobility criteria) to reduce DVT incidence.

Include documentation of immobility, duration of IPC use, and any contraindications to device use.

Post‑operative immobilized outpatients: Use IPC during periods of immobilization after surgery (eg, Achilles tendon repair) to reduce early DVT risk; document surgery, immobilization period, and rationale.

RCT evidence shows reduced early DVT incidence with IPC in selected postoperative patients.

Patients with high VTE risk and high bleeding risk: When pharmacologic prophylaxis is contraindicated due to high bleeding risk, IPC is recommended over no prophylaxis per ASH/European guidance; document bleeding risk and reasons pharmacologic prophylaxis is contraindicated.

Guideline‑based conditional recommendations support this use.

Lymphedema treatment per device clearance: Advanced pneumatic compression for head/neck lymphedema may be considered if used consistent with FDA clearance and supporting clinical evidence; document prior conservative therapy and device‑specific justification.

Device clearance (eg, Flexitouch Plus) and available clinical studies inform consideration; policy otherwise treats APCDs for head/neck as unproven unless criteria are met.

Documentation Required

Document clinical justification and benefit‑plan alignment

Provide clinical justification that demonstrates medical necessity and document how the request aligns with federal, state, or contractual benefit requirements and device labeling or guideline-based rationale.

DefinitionAdvanced pneumatic compression devices (APCDs): complex systems with multiple garment options and programmability intended to address specialized needs such as head/face/neck lymphedema, fibrosis, or localized swelling.

Regulatory noteAPCDs may have device-specific FDA clearances and supporting feasibility or clinical studies; clearance alone is informational, not sole coverage basis.

Evidence stanceAPCD use for head/face/neck lymphedema is discussed but considered insufficient/subject to specific policy coverage rules in some contexts.

Chronic limb-threatening ischemia (CLTI)

DefinitionChronic limb-threatening ischemia (CLTI): severe peripheral artery disease with rest pain or tissue loss where revascularization may not be possible.

Guideline recommendationESVS (2019) — consider IPC therapy in carefully selected CLTI patients (eg, rest pain, minor tissue loss) when revascularization is not possible (Grade 2B).

Coverage implicationArterial IPC may be considered for CLTI when revascularization is not an option; document specialist assessment and rationale.

Immobile post-stroke patient (trial definition)

Trial-based immobility definitionImmobile post-stroke patient (trial definition): not able to get up from a chair/out of bed and walk to the toilet without the help of another person.

Use in CLOTS3CLOTS3 inclusion used this immobility definition for allocation to IPC versus no IPC in acute stroke DVT prophylaxis trials.

Exclusion examplesTrials excluded patients with contraindications to IPC including dermatitis, leg ulcers, severe edema, severe peripheral vascular disease, or congestive cardiac failure.

FDA regulation class (JOW) for PCDs

FDA device classPneumatic compression devices are regulated by the FDA as Class II devices (product code JOW).

Coverage noteFDA clearance is informational and not alone a basis for coverage determinations.

Reference accessFDA product code JOW referenced for device listings and 510(k) information.

Flexitouch Plus System — FDA-cleared APCD for head/neck lymphedema

Device name & clearanceFlexitouch Plus System (Tactile Systems Technology, Inc) — FDA cleared December 20, 2020 for head and neck lymphedema.

Intended use per clearanceFlexitouch garments for head and neck are intended for use by professionals and patients under medical supervision to treat head and neck lymphedema.

Associated HCPCSAPCD head/neck appliance corresponds to codes such as E0659 in the policy's HCPCS list.